Stay updated on CDX-0159 in Prurigo Nodularis Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.

Latest updates to the CDX-0159 in Prurigo Nodularis Clinical Trial page
- Check2 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 was added to the page, and the previous notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check38 days agoChange DetectedA site-wide notice about a lapse in government funding and potential delays is now shown on the page. The page revision has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check45 days agoChange DetectedUI and metadata tweaks include displaying the glossary option and updating QC-related labels and revision text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page shows a new revision tag, updating from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a consolidated Locations section listing study sites across multiple states (Arizona, Florida, Michigan, New Mexico, New York, Oklahoma, Texas). Removed the prior state-specific location subsections (Arizona Locations, Florida Locations, Michigan Locations, New Mexico Locations, New York Locations, Oklahoma Locations, Texas Locations) and the HHS Vulnerability Disclosure link.SummaryDifference0.9%

Stay in the know with updates to CDX-0159 in Prurigo Nodularis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.